Bio-Techne Corp [TECH] stock is trading at $58.78, up 0.53%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TECH shares have gain 12.99% over the last week, with a monthly amount glided 13.28%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, TD Cowen started tracking the stock with Buy rating on July 09, 2025, and set its price target to $65. On May 30, 2025, Wells Fargo initiated with a Overweight rating and assigned a price target of $59 on the stock. KeyBanc Capital Markets downgraded its rating to a Sector Weight. Evercore ISI initiated its recommendation with a Outperform and recommended $75 as its price target on March 18, 2025. Robert W. Baird downgraded its rating to Neutral for this stock on February 19, 2025, and downed its price target to $68. In a note dated May 22, 2024, Citigroup downgraded an Neutral rating on this stock but restated the target price of $85.
Bio-Techne Corp [TECH] stock has fluctuated between $46.01 and $83.62 over the past year. Currently, Wall Street analysts expect the stock to reach $75 within the next 12 months. Bio-Techne Corp [NASDAQ: TECH] shares were valued at $58.78 at the most recent close of the market. An investor can expect a potential return of 27.59% based on the average TECH price forecast.
Analyzing the TECH fundamentals
Bio-Techne Corp [NASDAQ:TECH] reported sales of 1.21B for the trailing twelve months, which represents a growth of 4.20%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.06 and Total Capital is 0.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 57.86 points at the first support level, and at 56.94 for the second support level. However, for the 1st resistance point, the stock is sitting at 59.60, and for the 2nd resistance point, it is at 60.42.
Ratios To Look Out For
For context, Bio-Techne Corp’s Current Ratio is 3.71. In addition, the Quick Ratio stands at 2.58 and the Cash Ratio stands at 0.83. Considering the valuation of this stock, the price to sales ratio is 7.62, the price to book ratio is 4.57 and price to earnings (TTM) ratio is 71.65.
Transactions by insiders
Recent insider trading involved Herr Amy E., Director, that happened on Jun 09 ’25 when 1280.0 shares were sold. Officer, JOSHUA MOLHO completed a deal on Jun 09 ’25 to buy 1280.0 shares. Meanwhile, Director Herr Amy E. sold 1860.0 shares on Feb 14 ’25.
